Ibrutinib in Early-Stage Chronic Lymphocytic Leukemia: The Randomized, Placebo-Controlled, Double-Blind, Phase III CLL12 Trial | Journal of Clinical Oncology
PURPOSEThe CLL12 trial reassesses the watch-and-wait consensus for early-stage chronic lymphocytic leukemia (CLL) in the context of targeted therapies.METHODSThe German CLL Study Group conducted a randomized, double-blind, placebo-controlled phase III …